In 2023 and 2024, the agency removed 19 peptides from a list of products that compounding pharmacies are allowed to produce, citing risks associated with immunogenicity, toxicity, and impurity
That said, weight loss in people with diabetes is still clinically meaningful and often leads to: Improved glucose control Reduced medication requirements Lower cardiovascular risk Better energy levels and mobility Important considerations GLP-1 medications are not cosmetic weight-loss drugs
Protein intake of 1.22.0 g/kg (for active individuals) is commonly recommended in research to support muscle
2020 Feb;27(1):2835
Therefore, some beneficiaries with qualifying cardiovascular conditions were able to access Wegovy through their Part D plan before 2026
This selective targeting underpins their efficacy in enhancing insulin secretion, inhibiting glucagon release, and promoting metabolic control in diabetes management (29)